nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—Obstructive airways disorder—Methotrexate—psoriatic arthritis	0.023	0.023	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Auranofin—psoriatic arthritis	0.0196	0.0196	CcSEcCtD
Lorazepam—Pancytopenia—Auranofin—psoriatic arthritis	0.016	0.016	CcSEcCtD
Lorazepam—Jaundice—Auranofin—psoriatic arthritis	0.0147	0.0147	CcSEcCtD
Lorazepam—Agranulocytosis—Auranofin—psoriatic arthritis	0.0141	0.0141	CcSEcCtD
Lorazepam—Visual impairment—Auranofin—psoriatic arthritis	0.013	0.013	CcSEcCtD
Lorazepam—Pericardial effusion—Methotrexate—psoriatic arthritis	0.0127	0.0127	CcSEcCtD
Lorazepam—Alopecia—Auranofin—psoriatic arthritis	0.012	0.012	CcSEcCtD
Lorazepam—Suicidal ideation—Methylprednisolone—psoriatic arthritis	0.0112	0.0112	CcSEcCtD
Lorazepam—Mania—Methylprednisolone—psoriatic arthritis	0.0108	0.0108	CcSEcCtD
Lorazepam—Suicidal ideation—Dexamethasone—psoriatic arthritis	0.0102	0.0102	CcSEcCtD
Lorazepam—Suicidal ideation—Betamethasone—psoriatic arthritis	0.0102	0.0102	CcSEcCtD
Lorazepam—Mania—Dexamethasone—psoriatic arthritis	0.00985	0.00985	CcSEcCtD
Lorazepam—Mania—Betamethasone—psoriatic arthritis	0.00985	0.00985	CcSEcCtD
Lorazepam—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00941	0.00941	CcSEcCtD
Lorazepam—Suicidal ideation—Prednisone—psoriatic arthritis	0.0089	0.0089	CcSEcCtD
Lorazepam—Mania—Prednisone—psoriatic arthritis	0.00858	0.00858	CcSEcCtD
Lorazepam—Leukocytosis—Methylprednisolone—psoriatic arthritis	0.00838	0.00838	CcSEcCtD
Lorazepam—Constipation—Auranofin—psoriatic arthritis	0.00822	0.00822	CcSEcCtD
Lorazepam—Hypoxia—Methotrexate—psoriatic arthritis	0.00821	0.00821	CcSEcCtD
Lorazepam—Memory impairment—Prednisone—psoriatic arthritis	0.00795	0.00795	CcSEcCtD
Lorazepam—Pulmonary oedema—Prednisolone—psoriatic arthritis	0.00764	0.00764	CcSEcCtD
Lorazepam—Leukocytosis—Betamethasone—psoriatic arthritis	0.00762	0.00762	CcSEcCtD
Lorazepam—Leukocytosis—Dexamethasone—psoriatic arthritis	0.00762	0.00762	CcSEcCtD
Lorazepam—Paralysis—Methotrexate—psoriatic arthritis	0.00751	0.00751	CcSEcCtD
Lorazepam—Euphoric mood—Prednisolone—psoriatic arthritis	0.00738	0.00738	CcSEcCtD
Lorazepam—Delirium—Prednisone—psoriatic arthritis	0.00726	0.00726	CcSEcCtD
Lorazepam—Pulmonary oedema—Triamcinolone—psoriatic arthritis	0.00703	0.00703	CcSEcCtD
Lorazepam—Pulmonary oedema—Methylprednisolone—psoriatic arthritis	0.00701	0.00701	CcSEcCtD
Lorazepam—Stupor—Methotrexate—psoriatic arthritis	0.00699	0.00699	CcSEcCtD
Lorazepam—Euphoric mood—Triamcinolone—psoriatic arthritis	0.00679	0.00679	CcSEcCtD
Lorazepam—Euphoric mood—Methylprednisolone—psoriatic arthritis	0.00677	0.00677	CcSEcCtD
Lorazepam—Leukocytosis—Prednisone—psoriatic arthritis	0.00664	0.00664	CcSEcCtD
Lorazepam—Visual disturbance—Prednisolone—psoriatic arthritis	0.00658	0.00658	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Methylprednisolone—psoriatic arthritis	0.00658	0.00658	CcSEcCtD
Lorazepam—Pulmonary oedema—Betamethasone—psoriatic arthritis	0.00638	0.00638	CcSEcCtD
Lorazepam—Pulmonary oedema—Dexamethasone—psoriatic arthritis	0.00638	0.00638	CcSEcCtD
Lorazepam—Osteoarthritis—Prednisolone—psoriatic arthritis	0.00623	0.00623	CcSEcCtD
Lorazepam—Euphoric mood—Dexamethasone—psoriatic arthritis	0.00616	0.00616	CcSEcCtD
Lorazepam—Euphoric mood—Betamethasone—psoriatic arthritis	0.00616	0.00616	CcSEcCtD
Lorazepam—Apnoea—Methotrexate—psoriatic arthritis	0.00615	0.00615	CcSEcCtD
Lorazepam—Vomiting—Auranofin—psoriatic arthritis	0.00611	0.00611	CcSEcCtD
Lorazepam—Amnesia—Methylprednisolone—psoriatic arthritis	0.00609	0.00609	CcSEcCtD
Lorazepam—Rash—Auranofin—psoriatic arthritis	0.00606	0.00606	CcSEcCtD
Lorazepam—Dermatitis—Auranofin—psoriatic arthritis	0.00605	0.00605	CcSEcCtD
Lorazepam—Cardiac arrest—Prednisolone—psoriatic arthritis	0.00593	0.00593	CcSEcCtD
Lorazepam—Osteoarthritis—Triamcinolone—psoriatic arthritis	0.00573	0.00573	CcSEcCtD
Lorazepam—Osteoarthritis—Methylprednisolone—psoriatic arthritis	0.00572	0.00572	CcSEcCtD
Lorazepam—Nausea—Auranofin—psoriatic arthritis	0.00571	0.00571	CcSEcCtD
Lorazepam—Psychotic disorder—Methylprednisolone—psoriatic arthritis	0.00559	0.00559	CcSEcCtD
Lorazepam—Pulmonary oedema—Prednisone—psoriatic arthritis	0.00555	0.00555	CcSEcCtD
Lorazepam—Dysarthria—Methotrexate—psoriatic arthritis	0.00551	0.00551	CcSEcCtD
Lorazepam—Visual disturbance—Dexamethasone—psoriatic arthritis	0.00549	0.00549	CcSEcCtD
Lorazepam—Visual disturbance—Betamethasone—psoriatic arthritis	0.00549	0.00549	CcSEcCtD
Lorazepam—Irritability—Methylprednisolone—psoriatic arthritis	0.00546	0.00546	CcSEcCtD
Lorazepam—Cardiac arrest—Triamcinolone—psoriatic arthritis	0.00545	0.00545	CcSEcCtD
Lorazepam—Cardiac arrest—Methylprednisolone—psoriatic arthritis	0.00544	0.00544	CcSEcCtD
Lorazepam—Euphoric mood—Prednisone—psoriatic arthritis	0.00536	0.00536	CcSEcCtD
Lorazepam—Respiratory failure—Methotrexate—psoriatic arthritis	0.00531	0.00531	CcSEcCtD
Lorazepam—Lethargy—Betamethasone—psoriatic arthritis	0.00531	0.00531	CcSEcCtD
Lorazepam—Lethargy—Dexamethasone—psoriatic arthritis	0.00531	0.00531	CcSEcCtD
Lorazepam—Osteoarthritis—Betamethasone—psoriatic arthritis	0.0052	0.0052	CcSEcCtD
Lorazepam—Osteoarthritis—Dexamethasone—psoriatic arthritis	0.0052	0.0052	CcSEcCtD
Lorazepam—Cystitis noninfective—Methotrexate—psoriatic arthritis	0.00509	0.00509	CcSEcCtD
Lorazepam—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.00508	0.00508	CcSEcCtD
Lorazepam—Psychotic disorder—Betamethasone—psoriatic arthritis	0.00508	0.00508	CcSEcCtD
Lorazepam—Depressed level of consciousness—Methotrexate—psoriatic arthritis	0.00504	0.00504	CcSEcCtD
Lorazepam—Cystitis—Methotrexate—psoriatic arthritis	0.00504	0.00504	CcSEcCtD
Lorazepam—Irritability—Dexamethasone—psoriatic arthritis	0.00496	0.00496	CcSEcCtD
Lorazepam—Irritability—Betamethasone—psoriatic arthritis	0.00496	0.00496	CcSEcCtD
Lorazepam—Cardiac arrest—Betamethasone—psoriatic arthritis	0.00495	0.00495	CcSEcCtD
Lorazepam—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.00495	0.00495	CcSEcCtD
Lorazepam—Amnesia—Prednisone—psoriatic arthritis	0.00482	0.00482	CcSEcCtD
Lorazepam—Coma—Methotrexate—psoriatic arthritis	0.00477	0.00477	CcSEcCtD
Lorazepam—Bladder pain—Methotrexate—psoriatic arthritis	0.00472	0.00472	CcSEcCtD
Lorazepam—Pulmonary oedema—Methotrexate—psoriatic arthritis	0.00464	0.00464	CcSEcCtD
Lorazepam—Lethargy—Prednisone—psoriatic arthritis	0.00462	0.00462	CcSEcCtD
Lorazepam—Osteoarthritis—Prednisone—psoriatic arthritis	0.00453	0.00453	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Prednisone—psoriatic arthritis	0.00453	0.00453	CcSEcCtD
Lorazepam—Psychotic disorder—Prednisone—psoriatic arthritis	0.00442	0.00442	CcSEcCtD
Lorazepam—Bradycardia—Prednisolone—psoriatic arthritis	0.00439	0.00439	CcSEcCtD
Lorazepam—Irritability—Prednisone—psoriatic arthritis	0.00432	0.00432	CcSEcCtD
Lorazepam—Cardiac arrest—Prednisone—psoriatic arthritis	0.00431	0.00431	CcSEcCtD
Lorazepam—Visual impairment—Prednisolone—psoriatic arthritis	0.00416	0.00416	CcSEcCtD
Lorazepam—Bradycardia—Triamcinolone—psoriatic arthritis	0.00404	0.00404	CcSEcCtD
Lorazepam—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00403	0.00403	CcSEcCtD
Lorazepam—Visual disturbance—Methotrexate—psoriatic arthritis	0.00399	0.00399	CcSEcCtD
Lorazepam—Hallucination—Methylprednisolone—psoriatic arthritis	0.00394	0.00394	CcSEcCtD
Lorazepam—Lethargy—Methotrexate—psoriatic arthritis	0.00386	0.00386	CcSEcCtD
Lorazepam—Arrhythmia—Prednisolone—psoriatic arthritis	0.00385	0.00385	CcSEcCtD
Lorazepam—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00381	0.00381	CcSEcCtD
Lorazepam—Osteoarthritis—Methotrexate—psoriatic arthritis	0.00379	0.00379	CcSEcCtD
Lorazepam—Erythema—Prednisolone—psoriatic arthritis	0.00375	0.00375	CcSEcCtD
Lorazepam—Bradycardia—Dexamethasone—psoriatic arthritis	0.00366	0.00366	CcSEcCtD
Lorazepam—Bradycardia—Betamethasone—psoriatic arthritis	0.00366	0.00366	CcSEcCtD
Lorazepam—Irritability—Methotrexate—psoriatic arthritis	0.00361	0.00361	CcSEcCtD
Lorazepam—Erectile dysfunction—Prednisone—psoriatic arthritis	0.00361	0.00361	CcSEcCtD
Lorazepam—Hallucination—Dexamethasone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Lorazepam—Hallucination—Betamethasone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Lorazepam—Ataxia—Methotrexate—psoriatic arthritis	0.00356	0.00356	CcSEcCtD
Lorazepam—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Lorazepam—Vision blurred—Prednisolone—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Lorazepam—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00353	0.00353	CcSEcCtD
Lorazepam—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.0035	0.0035	CcSEcCtD
Lorazepam—Visual impairment—Betamethasone—psoriatic arthritis	0.00347	0.00347	CcSEcCtD
Lorazepam—Visual impairment—Dexamethasone—psoriatic arthritis	0.00347	0.00347	CcSEcCtD
Lorazepam—Erythema—Triamcinolone—psoriatic arthritis	0.00345	0.00345	CcSEcCtD
Lorazepam—Erythema—Methylprednisolone—psoriatic arthritis	0.00344	0.00344	CcSEcCtD
Lorazepam—Vertigo—Prednisolone—psoriatic arthritis	0.00337	0.00337	CcSEcCtD
Lorazepam—Convulsion—Prednisolone—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Lorazepam—Hypertension—Prednisolone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Lorazepam—Arrhythmia—Betamethasone—psoriatic arthritis	0.00321	0.00321	CcSEcCtD
Lorazepam—Arrhythmia—Dexamethasone—psoriatic arthritis	0.00321	0.00321	CcSEcCtD
Lorazepam—Bradycardia—Prednisone—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Lorazepam—Alopecia—Betamethasone—psoriatic arthritis	0.00318	0.00318	CcSEcCtD
Lorazepam—Alopecia—Dexamethasone—psoriatic arthritis	0.00318	0.00318	CcSEcCtD
Lorazepam—Erythema—Dexamethasone—psoriatic arthritis	0.00313	0.00313	CcSEcCtD
Lorazepam—Erythema—Betamethasone—psoriatic arthritis	0.00313	0.00313	CcSEcCtD
Lorazepam—Hallucination—Prednisone—psoriatic arthritis	0.00312	0.00312	CcSEcCtD
Lorazepam—Pancytopenia—Methotrexate—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Lorazepam—Vertigo—Triamcinolone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Lorazepam—Vertigo—Methylprednisolone—psoriatic arthritis	0.00309	0.00309	CcSEcCtD
Lorazepam—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Lorazepam—Convulsion—Triamcinolone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Lorazepam—Tachycardia—Prednisolone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Lorazepam—Convulsion—Methylprednisolone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Lorazepam—Hypertension—Triamcinolone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Lorazepam—Hypertension—Methylprednisolone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Lorazepam—Drowsiness—Methotrexate—psoriatic arthritis	0.00292	0.00292	CcSEcCtD
Lorazepam—Dry mouth—Triamcinolone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Lorazepam—Confusional state—Methylprednisolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Lorazepam—Vertigo—Dexamethasone—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Lorazepam—Vertigo—Betamethasone—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Lorazepam—Arrhythmia—Prednisone—psoriatic arthritis	0.0028	0.0028	CcSEcCtD
Lorazepam—Infection—Triamcinolone—psoriatic arthritis	0.0028	0.0028	CcSEcCtD
Lorazepam—Infection—Methylprednisolone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Lorazepam—Alopecia—Prednisone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Lorazepam—Tachycardia—Triamcinolone—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Lorazepam—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Lorazepam—Erythema—Prednisone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Lorazepam—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Lorazepam—Convulsion—Betamethasone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Lorazepam—Convulsion—Dexamethasone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Lorazepam—Hypertension—Dexamethasone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Lorazepam—Hypertension—Betamethasone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Lorazepam—Hypotension—Methylprednisolone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Lorazepam—Pain—Prednisolone—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Lorazepam—Vision blurred—Prednisone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Lorazepam—Infection—Betamethasone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Lorazepam—Infection—Dexamethasone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Lorazepam—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Lorazepam—Visual impairment—Methotrexate—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Lorazepam—Agitation—Prednisone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Lorazepam—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Lorazepam—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Lorazepam—Tachycardia—Dexamethasone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Lorazepam—Tachycardia—Betamethasone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Lorazepam—Vertigo—Prednisone—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Lorazepam—Fatigue—Triamcinolone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Lorazepam—Fatigue—Methylprednisolone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Lorazepam—Pain—Triamcinolone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Lorazepam—Hypotension—Dexamethasone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Lorazepam—Hypotension—Betamethasone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Lorazepam—Convulsion—Prednisone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Lorazepam—Hypertension—Prednisone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Lorazepam—Chills—Methotrexate—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Lorazepam—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Lorazepam—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Lorazepam—Alopecia—Methotrexate—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Lorazepam—Erythema—Methotrexate—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Lorazepam—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Lorazepam—Infection—Prednisone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Lorazepam—Fatigue—Betamethasone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Lorazepam—Fatigue—Dexamethasone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Lorazepam—Pain—Dexamethasone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Lorazepam—Pain—Betamethasone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Lorazepam—Tachycardia—Prednisone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Lorazepam—Vision blurred—Methotrexate—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Lorazepam—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Lorazepam—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Lorazepam—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Lorazepam—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Lorazepam—Vertigo—Methotrexate—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Lorazepam—Dizziness—Prednisolone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Lorazepam—Asthenia—Triamcinolone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Lorazepam—Asthenia—Methylprednisolone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Lorazepam—Convulsion—Methotrexate—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Lorazepam—Rash—Prednisolone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Lorazepam—Dermatitis—Prednisolone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Lorazepam—Fatigue—Prednisone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Lorazepam—Headache—Prednisolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Lorazepam—Constipation—Prednisone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Lorazepam—Confusional state—Methotrexate—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Lorazepam—Dizziness—Triamcinolone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Lorazepam—Dizziness—Methylprednisolone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Lorazepam—Infection—Methotrexate—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Lorazepam—Feeling abnormal—Prednisone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Lorazepam—Asthenia—Dexamethasone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Lorazepam—Asthenia—Betamethasone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Lorazepam—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Lorazepam—Nausea—Prednisolone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Lorazepam—Vomiting—Triamcinolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Lorazepam—Vomiting—Methylprednisolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Lorazepam—Rash—Triamcinolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Lorazepam—Dermatitis—Triamcinolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Lorazepam—Rash—Methylprednisolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Lorazepam—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Lorazepam—Headache—Triamcinolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Lorazepam—Headache—Methylprednisolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Lorazepam—Hypotension—Methotrexate—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Lorazepam—Dizziness—Dexamethasone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Lorazepam—Dizziness—Betamethasone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Lorazepam—Nausea—Triamcinolone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Lorazepam—Nausea—Methylprednisolone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Lorazepam—Somnolence—Methotrexate—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Lorazepam—Hypersensitivity—Prednisone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Lorazepam—Vomiting—Betamethasone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Lorazepam—Vomiting—Dexamethasone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Lorazepam—Rash—Dexamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Lorazepam—Rash—Betamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Lorazepam—Dermatitis—Dexamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Lorazepam—Dermatitis—Betamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Lorazepam—Fatigue—Methotrexate—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Lorazepam—Headache—Betamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Lorazepam—Headache—Dexamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Lorazepam—Asthenia—Prednisone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Lorazepam—Pain—Methotrexate—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Lorazepam—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Lorazepam—Nausea—Dexamethasone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Lorazepam—Nausea—Betamethasone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Lorazepam—Dizziness—Prednisone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Lorazepam—Vomiting—Prednisone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Lorazepam—Rash—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Lorazepam—Dermatitis—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Lorazepam—Headache—Prednisone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Lorazepam—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Lorazepam—Asthenia—Methotrexate—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Lorazepam—Nausea—Prednisone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Lorazepam—Dizziness—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Lorazepam—Vomiting—Methotrexate—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Lorazepam—Rash—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Lorazepam—Dermatitis—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Lorazepam—Headache—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Lorazepam—Nausea—Methotrexate—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
